Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 1
2016 1
2017 1
2018 3
2019 14
2020 9
2021 10
2022 7
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Small-molecule inhibition of the archetypal UbiB protein COQ8.
Murray NH, Asquith CRM, Fang Z, East MP, Ptak N, Smith RW, Vasta JD, Zimprich CA, Corona CR, Robers MB, Johnson GL, Bingman CA, Pagliarini DJ. Murray NH, et al. Among authors: asquith crm. Nat Chem Biol. 2023 Feb;19(2):230-238. doi: 10.1038/s41589-022-01168-3. Epub 2022 Oct 27. Nat Chem Biol. 2023. PMID: 36302899 Free PMC article.
PKN3: a target in cancer metastasis.
Temme L, Laitinen T, Asquith CRM. Temme L, et al. Among authors: asquith crm. Nat Rev Drug Discov. 2022 Oct;21(10):704. doi: 10.1038/d41573-022-00154-7. Nat Rev Drug Discov. 2022. PMID: 36104477 No abstract available.
RIOK2: straddling the kinase/ATPase line.
Asquith CRM, East MP, Zuercher WJ. Asquith CRM, et al. Nat Rev Drug Discov. 2019 Jul;18(8):574. doi: 10.1038/d41573-019-00107-7. Nat Rev Drug Discov. 2019. PMID: 31367048 No abstract available.
eEF2K: an atypical kinase target for cancer.
Temme L, Asquith CRM. Temme L, et al. Among authors: asquith crm. Nat Rev Drug Discov. 2021 Aug;20(8):577. doi: 10.1038/d41573-021-00124-5. Nat Rev Drug Discov. 2021. PMID: 34257429 No abstract available.
STK19: a new target for NRAS-driven cancer.
Asquith CRM, Temme L. Asquith CRM, et al. Nat Rev Drug Discov. 2020 Sep;19(9):579. doi: 10.1038/d41573-020-00116-x. Nat Rev Drug Discov. 2020. PMID: 32587355 No abstract available.
PKMYT1: a forgotten member of the WEE1 family.
Asquith CRM, Laitinen T, East MP. Asquith CRM, et al. Nat Rev Drug Discov. 2020 Mar;19(3):157. doi: 10.1038/d41573-019-00202-9. Nat Rev Drug Discov. 2020. PMID: 32127662 No abstract available.
50 results